Roeland Nusse Bio Techne Corp (TECH) insider trading activity

Roeland Nusse is Director of BIO-TECHNE Corp. Currently has a direct ownership of 44,559 shares of TECH, which is worth approximately $2.48 Million. The most recent transaction as insider was on Aug 25, 2025, when has been sold 17,040 shares (Common Stock) at a price of $56.36 per share, resulting in proceeds of $960,374. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 44.6K

0% 3M change

3.39% 12M change

Total Value Held $2.48 Million

Roeland Nusse Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 25 2025	SELL Open market or private sale	$960,374 $56.36 p/Share	17,040 Reduced 27.66%	44,559 Common Stock
Aug 25 2025	BUY Exercise of conversion of derivative security	$372,153 $21.84 p/Share	17,040 Added 21.67%	61,599 Common Stock
Oct 24 2024	BUY Grant, award, or other acquisition	-	1,462 Added 3.18%	44,559 Common Stock
Mar 07 2024	SELL Open market or private sale	$800,592 $76.98 p/Share	10,400 Reduced 19.44%	43,097 Common Stock
Oct 26 2023	BUY Grant, award, or other acquisition	-	1,625 Added 2.95%	53,497 Common Stock
Aug 30 2023	SELL Open market or private sale	$717,980 $80.32 p/Share	8,939 Reduced 14.7%	51,872 Common Stock
Aug 30 2023	BUY Exercise of conversion of derivative security	$716,800 $22.4 p/Share	32,000 Added 34.48%	60,811 Common Stock
Apr 19 2023	SELL Bona fide gift	-	377 Reduced 1.29%	28,811 Common Stock
Oct 27 2022	BUY Grant, award, or other acquisition	-	338 Added 4.43%	7,297 Common Stock
Oct 28 2021	BUY Grant, award, or other acquisition	-	194 Added 2.71%	6,959 Common Stock
Aug 23 2021	SELL Open market or private sale	$1,926,080 $481.52 p/Share	4,000 Reduced 37.16%	6,765 Common Stock
Aug 23 2021	BUY Exercise of conversion of derivative security	$281,400 $70.35 p/Share	4,000 Added 27.09%	10,765 Common Stock
Feb 08 2021	SELL Open market or private sale	$2,310,480 $385.08 p/Share	6,000 Reduced 47.0%	6,765 Common Stock
Feb 08 2021	BUY Exercise of conversion of derivative security	$411,780 $68.63 p/Share	6,000 Added 31.97%	12,765 Common Stock
Oct 29 2020	BUY Grant, award, or other acquisition	-	391 Added 2.97%	12,765 Common Stock

Roeland Nusse

Director

Palo Alto, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TECH shares.

Notify only if

Value

Insider Trading

Get notified when an Bio Techne Corp insider buys or sells TECH shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIO-TECHNE Corp

Track Activities on TECH

Account